33. Considers that the use of so called ‘last resort’ antibiotics targeting problematic human pathogens should be prohibited for agricultural use;

The directive amending the directive on the Community code relating to medicinal products for human use now entitles the Member States temporarily to permit the distribution of authorised medicinal products in the case of an attack involving the spread of pathogens, toxins, chemical agents or nuclear radiation.

(12) There is also a relationship between the occurrence of antimicrobial resistance in certain human pathogens and their occurrence in animals and the environment.

3. Without prejudice to paragraph 1, Member States shall lay down provisions in order to ensure that marketing authorisation holders, manufacturers and health professionals are not subject to civil or administrative liability for any consequences resulting from the use of a medicinal product otherwise than for the authorised indications or from the use of an unauthorised medicinal product, when such use is recommended or required by a competent authority in response to the suspected or confirmed spread of pathogenic agents, toxins, ...[+++]chemical agents or nuclear radiation any of which could cause harm.

2. Member States may temporarily authorise the distribution of an unauthorised medicinal product in response to the suspected or confirmed spread of pathogenic agents, toxins, chemical agents or nuclear radiation any of which could cause harm.

2. Member States may temporarily authorise the distribution of an unauthorised medicinal product in response to the suspected or confirmed spread of pathogenic agents, toxins, chemical agents or nuclear radiation any of which could cause harm.